Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis.
Bingen
E
E
Service de Microbiologie, Hôpital Robert Debré, Paris, France.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D018849:Controlled Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D007769:Lactams / Q000008:administration & dosage; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D007769:Lactams